InvestorGain adds Buybacks & Authorizations, New Issues & Calendars, Blogs, and Education coverage that IPOScoop skips.
VOL. XCIV, NO. 247
★ FINANCIAL TOOLS & SERVICES DIRECTORY ★
PRICE: 5 CENTS
Monday, October 6, 2025
Head-to-head
InvestorGain vs IPOScoop comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Quick takeaways
IPOScoop includes News, Scores, and Regulatory Filings Monitoring categories that InvestorGain omits.
InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..
IPOScoop is known for: IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”, SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology., and Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes..
InvestorGain ships a mobile app. IPOScoop is web/desktop only.
InvestorGain
investorgain.com
India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.
Categories
Platforms
Pricing
Quick highlights
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
- Rights issues dashboard (record date, entitlement, pricing, timelines).
Community votes (overall)
IPOScoop
iposcoop.com
U.S.-focused IPO tracker with calendars, profiles, and editorial coverage. Free sections include the IPO Calendar, Pricings, Last 100, and Last 12 Months. Subscriber access unlocks SCOOP Ratings, quiet-period and lock-up trackers, and certain detailed fields on IPO pages. A corporate XML feed is also available for institutional clients.
Platforms
Pricing
Quick highlights
- IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”
- SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology.
- Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes.
- Quiet-period and lock-up expiration trackers (specific dates available to subscribers only).
- Pipeline tools to view IPOs by managers, by industry, or by recent filings.
Community votes (overall)
Shared focus areas
3 overlapsMutual strengths include IPO, Secondary Offerings, and Calendar.
Where they differ
InvestorGain
Distinct strengths include:
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
IPOScoop
Distinct strengths include:
- IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”
- SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology.
- Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes.
- Quiet-period and lock-up expiration trackers (specific dates available to subscribers only).
Feature-by-feature breakdown
Attribute | InvestorGain | IPOScoop |
---|---|---|
Categories Which research workflows each platform targets | Shared: IPO, Secondary Offerings, Calendar Unique: Buybacks & Authorizations, New Issues & Calendars, Blogs, Education | Shared: IPO, Secondary Offerings, Calendar Unique: News, Scores, Regulatory Filings Monitoring |
Asset types Supported asset classes and universes | Stocks, Bonds | Stocks |
Experience levels Who each product is built for | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web, Mobile | Web |
Pricing High-level pricing models | Free | Free, Subscription |
Key features Core capabilities called out by each vendor | Unique
| Unique
|
Tested Verified by hands-on testing inside Find My Moat | Not yet | Yes |
Editor pick Featured inside curated shortlists | Standard listing | Standard listing |
Frequently Asked Questions
Which workflows do InvestorGain and IPOScoop both support?
Both platforms cover IPO, Secondary Offerings, and Calendar workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do InvestorGain and IPOScoop require subscriptions?
Both InvestorGain and IPOScoop keep freemium access with optional paid upgrades, so you can trial each platform before committing.
Which tool has mobile access?
InvestorGain ships a dedicated mobile experience, while IPOScoop focuses on web or desktop access.
What unique strengths set the two platforms apart?
InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas IPOScoop stands out for IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”, SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology., and Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes..
Keep exploring
Stay on top of related tools
Browse the categories and profiles that overlap most with this comparison to round out your shortlist.
Related categories
Follow the same themes these tools compete in.
Recommended tools
These profiles share overlapping coverage with both sides of this matchup.
- IPO Watch (ipowatch.in)
Overlap: IPO, Buybacks & Authorizations, and Secondary Offerings.
IPOBuybacks & AuthorizationsSecondary Offerings - StockopediaEditor's pickHands-on review
Overlap: Scores, News, and Calendar.
ScoresNewsCalendar - Chittorgarh.com
Overlap: IPO, Secondary Offerings, and News.
IPOSecondary OfferingsNews - SEC EDGAR — Company Filings (Full‑Text Search & Search Filings)
Overlap: Regulatory Filings Monitoring, IPO, and Secondary Offerings.
Regulatory Filings MonitoringIPOSecondary Offerings - SEDAR+ (CSA Public Filings — Canada)
Overlap: Regulatory Filings Monitoring, IPO, and Secondary Offerings.
Regulatory Filings MonitoringIPOSecondary Offerings - CapEdgeEditor's pickHands-on review
Overlap: News, Calendar, and IPO.
NewsCalendarIPO
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.